 |
Nepal for the first time that the private sector bhenam anti-snake deadly snake to escape the drug has been established. The Government of Nepal in a single year to purchase 30 thousand bhayala drug has anti-snake venom.
On Monday, at a press conference in Itahari, Sunsari entisneka vials seruma Research and menuphyakcarina Pvt Ltd started its production within 2 years of information is given. About 88 million cost of the operation will come Mahendranagar Sunsari 15 million per year bhayala drug company is going to produce.
Resistance now be imported from India in Nepal, the patient is undergoing treatment at the victims of the serpent dasaibata. If the same drug in Nepal to become the company's chairman Lakshmi Prasad intuitive way possible treatment Phunyal said.
The Government of Nepal now has to purchase annually 30 thousand bhayala medicine. Whose market value is about 4 million affected. The company produces 15 million market value of 13 billion 53 million bhayala medicine will be unpleasant. The company produces large quantities of the drug to sell the Government of Nepal and the rest of the export market to foreign pharmaceutical companies to prepare for the moment. According to the World Health Organization to leakage around the world every year pratilakha 1 hundred and 62 people were killed when the snake is deadly. About 1 thousand people have died in Nepal a year of deadly snakes of different survey showed. The government did the snake dasaiko drug free when its time to lose their lives to a premature victim after a miss.
|
This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.
ConversionConversion EmoticonEmoticon